ArticleCase reports in dentistry2026
Recurrent Ameloblastoma of the Mandibular Ramus Resected Using a Modified High Perimandibular Approach: A Case Report.
Article in Case reports in dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recurrent Ameloblastoma of the Mandibular Ramus Resected Using a Modified High Perimandibular Approach: A Case Report.Case reports in dentistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ameloblastoma typically lacks a well-defined capsule and exhibits locally invasive growth, making them prone to recurrence. On the other hand, a subtype known as the unicystic type is generally well circumscribed and less invasive compared with conventional solid/multicystic variants, but recurrence may occur in rare cases. Therefore, after tumor removal, it is essential to resect or curette the adjacent bone surface that may have been infiltrated. The high perimandibular approach is a surgical technique originally developed for treating condylar fractures. It involves a 4-5 cm skin incision placed 5 mm below the lower border of the mandible, followed by incision of the platysma and masseter muscles above the course of the mandibular branch of the facial nerve, thereby protecting the nerve. Compared with other surgical approaches, this method provides a wide operative field and superior esthetic outcomes, as postoperative scars are less conspicuous. In this report, we describe a case in which this approach was adapted for resecting a recurrent ameloblastoma of the mandibular ramus. The patient was a 58-year-old man who presented to our department in May 2016 with a lesion extending from the right mandibular body to the mandibular ramus. A diagnosis of ameloblastoma unicystic type was established, and fenestration procedures were performed in May 2017. However, further treatment was discontinued at the patient's request. The tumor subsequently recurred on the lateral surface of the right mandibular ramus, measuring 28 mm × 14 mm. In May 2022, the lesion was resected using the extended high perimandibular approach: an extended incision of 10 cm, twice the usual length, provided sufficient surgical exposure to allow for safe and effective complete tumor removal. Postoperatively, no facial nerve paralysis occurred, and no recurrence was observed during 3 years of follow-up. Esthetic outcomes were satisfactory. In conclusion, the extended high perimandibular approach may be a useful surgical option for managing recurrent ameloblastoma on the lateral surface of the mandibular ramus.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.